Haloalkyl complexes of the transition metals: IV. The formation of a cationic ylide complex of platinum(II) from a chloromethylplatinum(II) complex and the crystal structures of cis-[Pt(CH2PPh3)X(PPh3)2]I (X = Cl or I)

The reactions of Pt(PPH₃)₄ and Pt(C₂H₄)(PPh₃)₂ with CH₂ClI have been investigated. The product of the reaction of Pt(PPh₃)₄ with CH₂ClI is the cationic ylide complex cis-[Pt(CH₂PPh₃)Cl(PPh₃)2][I], whereas the reaction of Pt(C₂H₄)-(PPh₃)₂ gives the oxidative addition product Pt(CH₂Cl)I(PPh₃)₂. Reaction of cis- or trans-Pt(CH₂Cl)I(PPh₃)₂] with PPh₃ gives the complex cis-[Pt(CH₂PPh₃)-Cl(PPh₃)₂][I]. The structures of the complexes cis-[Pt(CH₂PPh₃X(PPh₃)₂][I] (where X = Cl or I) have been determined by X-ray crystallography. Both complexes crystalize in the monoclinic space group P2₁/n. For X = Cl a 1388.6(7), b 2026.7(10), c 1823.9(9) pm, β 96.51(2)° and R converged to 0.075 for 3542 observed reflections; structural parameters Pt-Cl 240(1), Pt-C(3) 212(2), Pt-P(2) (trans to Cl) 235(1) and Pt-P(1) (trans to CH₂PPh₃) 233(1) pm; Cl-Pt-C(3) 86.9(5), C(3)-Pt-P(2) 91.8(5), P(2)-Pt-P(1) 97.0(2) and P(1)-Pt-Cl 85.1(2)°. For X = I, a 1379.4(7), b 2044.4(10), c 1840.0(9) pm, β 96.09(2)° and R converged to 0.071 for 4333 observed reflections; structural parameters Pt-I 266(1), Pt-C(3) 212(2), Pt-P(2) (trans to I) 226(1) and Pt-P(1) (trans to CH₂PPh₃ 233(1) pm; I-Pt-C(3) 87.2(5), C(3)-Pt-P(2) 91.5(5), P(2)-Pt-P(1) 96.5(2) and P(1)-Pt-I 85.6(1)°. Some other complexes of the type cis-[Pt(CH₂PPh₃)X(PPh₃)₂]Y are also described.     

Synthesis of new thietanylpyrimidine and thietanylimidazole derivatives

New thietanyl-substituted derivatives of pyrimidine-2,4(1H,3H)-dione and imidazole were synthesized. The alkylation of 6-methylpyrimidine-2,4(1H,3H)-diones with 2-chloromethylthiirane in water involved the N¹ atom of the pyrimidine ring and afforded 6-methyl-1-(thietan-3-yl)-pyrimidine-2,4(1H,3H)-diones. Under analogous conditions 6-aminopyrimidine-2,4(1H,3H)-dione gave rise to 6-(thietan-3-ylamino)pyrimidine-2,4(1H,3H)-dione. Unsymmetrically substituted 2-methyl-4(5)-nitro- and 5(4)-bromo-2-methyl-4(5)-nitro-1H-imidazoles reacted with 2-chloromethylthiirane to produce mixtures of isomeric 2-methyl-4(5)-nitro-1-(thietan-3-yl)-1H-imidazoles and 5(4)-bromo-2-methyl-4(5)-nitro-1-(thietan-3-yl)-1H-imidazoles.     

Synthesis,structure elucidation and plants growth promoting effects of novel quinolinyl chalcones

The readily synthesized 3-(4-Hydroxy-1-methyl-1,2-dihydro-2-oxoquinolin-3-yl)-1-phenyl-1H-pyrazole-4-carbaldehyd (5) and 3-(2-Oxo-2H-chromen-3-yl)-1-phenyl-1H-pyrazole-4-carbaldehyde (6) were utilized as a convenient starting precursor materials for synthesis of novel enone system 4-hydroxy-1-methyl-3-(4-(2H-2-oxo-chromen-3-yl)prop-2-enoyl)-1-phenyl-1H-pyrazol-4-yl)quinolin-2(1H)-one (7) and4-hydroxy-1-methyl-3-(2E)-3-(3-(2-oxo-2H-chromen-3-yl)-1-phenyl-1H-pyrazol-4-yl)acryloyl)quinolin-2(1H)-one (8). Simple homonuclear NOE experiment (NOESY 1D) method was performed for structure elucidation of the novel quinolinyl chalcones. The synthesized compounds have been estimated for their effect of growth on some selective crop of plants (Hibiscus, Mint and Basil).     

Crystal structures of new isostructural oxovanadium(V) complexes with hydrazone ligands

Two new isostructural methoxide-bridged dimeric oxovanadium(V) complexes [VO(L¹)(OMe)]₂ (1) and [VO(L²)(OMe)]₂ (2), where L¹ and L² are the deprotonated forms of 3-bromo-N′-[1-(2-hydroxyphenyl)×ethylidene]benzohydrazide (H₂L¹) and 3-chloro-N′-[1-(2-hydroxyphenyl)ethylidene]benzohydrazide (H₂L²) respectively, are synthesized and characterized by elemental analyses, IR spectra, and single crystal X-ray determination. Both crystals crystallize in the triclinic space group P-1. For 1, a = 7.5237(15) Å, b = 10.846(3) Å, c = 11.195(3) Å, α = 84.143(3)°, β = 72.244(3)°, γ = 77.869(3)°, V = 849.9(4) ų, Z = 1, R ₁ = 0.0634, wR ₂ = 0.1373. For 2, a = 7.493(2) Å, b = 10.740(3) Å, c = 11.109(3) Å, α = 84.569(2)°, β = 71.783(2)°, γ = 79.822(2)°, V = 835.0(4) ų, Z = 1, R ₁ = 0.0511, wR ₂ = 0.1076. Each V atom in the complexes is octahedrally coordinated.     

Chemistry of Spontaneous Alkylation of Methimazole with 1,2-Dichloroethane

Spontaneous S-alkylation of methimazole (1) with 1,2-dichloroethane (DCE) into 1,2-bis[(1-methyl-1H-imidazole-2-yl)thio]ethane (2), that we have described recently, opened the question about its formation pathway(s). Results of the synthetic, NMR spectroscopic, crystallographic and computational studies suggest that, under given conditions, 2 is obtained by direct attack of 1 on the chloroethyl derivative 2-[(chloroethyl)thio]-1-methyl-1H-imidazole (3), rather than through the isolated stable thiiranium ion isomer, i.e., 7-methyl-2H, 3H, 7H-imidazo[2,1-b]thiazol-4-ium chloride (4a, orthorhombic, space group Pnma), or in analogy with similar reactions, through postulated, but unproven intermediate thiiranium ion 5. Furthermore, in the reaction with 1, 4a prefers isomerization to the N-chloroethyl derivative, 1-chloroethyl-2,3-dihydro-3-methyl-1H-imidazole-2-thione (7), rather than alkylation to 2, while 7 further reacts with 1 to form 3-methyl-1-[(1-methyl-imidazole-2-yl)thioethyl]-1H-imidazole-2-thione (8, monoclinic, space group P 2₁/c). Additionally, during the isomerization of 3, the postulated intermediate thiiranium ion 5 was not detected by chromatographic and spectroscopic methods, nor by trapping with AgBF₄. However, trapping resulted in the formation of the silver complex of compound 3, i.e., bis-{2-[(chloroethyl)thio]-1-methyl-1H-imidazole}-silver(I)tetrafluoroborate (6_, monoclinic, space group P 2₁/c), which cyclized upon heating at 80 °C to 7-methyl-2H, 3H, 7H-imidazo[2,1-b]thiazol-4-ium tetrafluoroborate (4b, monoclinic, space group P 2₁/c). Finally, we observed thermal isomerization of both 2 and 2,3-dihydro-3-methyl-1-[(1-methyl-1H-imidazole-2-yl)thioethyl]-1H-imidazole-2-thione (8), into 1,2-bis(2,3-dihydro-3-methyl-1H-imidazole-2-thione-1-yl)ethane (9), which confirmed their structures.     

Monomeric five-coordinate rhenium diazenido and hydrazido complexes with aromatic thiolate ligands: X-ray structures of [Re(NNC6H4-Br)2(SC6H3-2,5-Me2)(PPh3)2] and [ReO(NNMePh)(SPh)3], and of the synthetic precursor [Re(NNC6H4-4-Br)2Cl(PPh3)2]

Reaction of [ReOCl₃(PPh₃)₂] with bromophenylhydrazine in methanol yields [ReCl(N₂C₆H₄Br)₂(PPh₃)₂] (1). Complex 1 reacts with arylthiolates to give mixtures of [Re(SAr)(N₂C₆H₄Br)₂(PPh₃)₂] (2) and [Re₂(SAr)₇(NNR)₂]⁻. Complexes 1 and 2 display trigonal bipyramidal geometries with the phosphine ligands occupying the axial sites. A significant feature of the structures is the nonequivalence of the rhenium-diazenido moieties, such that for 1 the ReN(1) and N(1)N(2) distances are 1.80(2) and 1.24(3) Å, while ReN(3) and N(3)N(4) are 1.73(2) and 1.32(3) Å, and for 2 the ReN distances are 1.73(1) and 1.80(2)° with corresponding NN distances of 1.32(2) and 1.25(2) Å. Reaction of (PPh₄)[ReO(SPh)₄] (3) with unsymmetrically disubstituted hydrazines affords complexes of the type [ReO(SPh)₃(NMRR′)] (R = Me, R′ = Ph for 4). Complexes 3 and 4 display distorted square pyramidal geometries with the oxo groups apical. The significant feature of the structure of 4 is the nonlinear ReN(1)N(2) linkage, exhibiting an angle of 145.6(10)°. The angle does not appear to correlate with a significant contribution from a valence form with sp² hybridization at the α-nitrogen. Crystal data: 1: monoclinic space group, P2₁/n, a = 12.216(2) Å, b = 19.098(2) Å, c = 20.257(4) Å, β = 106.20(1)°, V = 4538.3(8) ų to give Z = 4; structure solution and refinement based on 1905 reflections converged at R = 0.070. 2: monoclinic space group P2₁/n, a = 14.393(2) Å, b = 18.842(3) Å, c = 20.717(4)Å, β = 110.26(1)°, V = 5270.5(8) ų to give Z = 4 for D = 1.53 g cm⁻¹; structure solution and refinement based on 4249 reflections to give R = 0.070. 3: monoclinic space group P2₁/n, a = 12.531(2) Å, b = 24.577(4) Å, c = 16.922(3) Å, β = 99.06(1)°, V = 5146.2(9) ų, D = 1.36 g cm⁻³ for Z = 4, 2912 reflections, R = 0.050. 4: monoclinic space group p2₁/n, a = 16.137(2) Å, b = 9.863(2) Å, c = 16.668(2) Å, β = 111.12(1)°, V = 2474.7(6) ų, D = 1.74 g cm⁻³ for Z = 4, 2940 reflections, R = 0.066.     

Studies towards the synthesis of (1R,2S)- and (1S,2S)-1,2-epoxy-3-hydroxypropylphosphonates and (1S,2S)- and (1R,2S)-2,3-epoxy-1-hydroxypropylphosphonates

The trans-configured fosfomycin analogue, diethyl (1S,2S)-1,2-epoxy-3-hydroxypropylphosphonate, was synthesised by the intramolecular Williamson reaction of diethyl (1S,2R)-1,3-dihydroxy-2-mesyloxypropylphosphonate. The cis-analogue was obtained as O-ethyl or O,O-diethyl (1R,2S)-1,2-epoxy-3-hydroxypropylphosphonates, when (1R,2R)-1,3-dihydroxy-2-mesyloxypropylphosphonate or its 3-O-trityl derivative were used as starting materials, respectively. The intramolecular Williamson cyclisations of diethyl (1S,2R)- and (1R,2S)-1-benzyloxy-3-hydroxy-2-mesyloxypropylphosphonates led to diethyl (1S,2S)- and (1R,2S)-2,3-epoxy-1-benzyloxypropylphosphonates, respectively, with the concomitant formation of diethyl (E)-1-benzyloxy-3-hydroxyprop-1-en-1-phosphonate. From diethyl (1S,2S)- and (1R,2S)-2,3-epoxy-1-benzyloxypropylphosphonates, enantiomerically pure diethyl (1S,2S)- and (1R,2S)-1,2-dihydroxypropylphosphonates were obtained by catalytic hydrogenation, while diethyl (1S,2S)- and (1R,2S)-3-acetamido-1,2-dihydroxypropylphosphonates were produced after epoxide ring opening with dibenzylamine, acetylation and hydrogenolysis.     

Divalent transition metal phosphonates with new structure containing hydrogen-bonded layers of phosphonate anions

A series of divalent transition metal phosphonates containing hydrogen-bonded layers of phosphonate anions, namely [M(phen)₃]·C₆H₅PO₃·11H₂O [M=Co(1), Ni(2), Cu(3)] and [Cd(phen)₃]·C₆H₅PO₃H·Cl·7H₂O (4) have been synthesized, structurally characterized by single-crystal X-ray diffraction method. These compounds all crystallize in the triclinic system, space group P-1. The lattice parameters are a=12.1646(5), b=12.4155(6), c=15.4117(10) Å, α=78.216(2), β=79.735(3), γ=77.8380(3)°, V=2205.1(2) Å³, Z=2 for 1; a=12.097(2), b=12.606(3), c=15.742(3) Å, α=76.66(3), β=80.04(3), γ=77.75(3)°, V=2263.4(8) Å³, Z=2 for 2; a=12.058(2), b=12.518(3), c=15.781(3) Å, α=77.77(3), β=80.02(3), γ=77.91(3)°, V=2255.5(8) Å³, Z=2 for 3 and a=12.47680(10), b=12.6693(2), c=16.1504(3) Å, α=82.600(1), β=71.122(1), γ=77.355(1)°, V=2352.37(6) Å³, Z=2 for 4. All structures are refined by full-matrix least-squares methods [for 1, R1=0.0602 using 6458 independent reflections with I>2σ(I); for 2, R1=0.0632 using 4657 independent reflections with I>2σ(I); for 3, R1=0.0634 using 6221 independent reflections with I>2σ(I); for 4, R1=0.0400 using 7930 independent reflections with I>2σ(I)]. In the crystal structures, the phenylphosphonate anions and water molecules are hydrogen-bonded to form layers, and there exist the cationic species [M(phen)₃]²⁺ between the adjacent layers of anions and water. Luminescence, thermal analysis as well as IR spectroscopic studies are also presented.     

Microwave synthesis,characterization and antimicrobial study of new pyrazolyl-oxopropyl-quinazolin-4(3H)-one derivatives

Heterocyclic compounds containing pyrazolyl-oxopropyl-quinazolin-4(3H)-one are reported to possess significant biological activity. Syntheses of 6-bromo-2-(3-chloro-2-oxopropyl)-3-(4-fluorophenyl)quinazolin-4(3H)-one 2 6-bromo-3-(4-fluorophenyl)-2-(3-hydrazinyl-2-oxopropyl)quinazolin-4(3H)-one 3 and 6-bromo-2-(3-(3-(4-(1-(2-chlorophenyl)-3-methyl-1H-pyrazol-5(4H)-ylideneamino)phenyl)-5-(substituted phenyl)-4,5-dihydro-1H-pyrazol-1-yl)-2-oxopropyl)-3-(4-fluorophenyl)quinazolin-4(3H)-one 5a–j using microwave irradiation have been described. These compounds have been characterized on the basis of the UV, IR, ¹H NMR, ¹³C NMR, Mass and elemental analysis. Compounds have been evaluated for their antimicrobial activity.     

Stereochemical consequence in the elimination of β-hydroxyalkylsilanes: Stereoselective formation of (Z)- and (E)-alkylidene-γ-butyrolactones

Titanium(IV) chloride-mediated reaction of 4,5-dihydro-2-(trimethylsiloxy)-3-(trimethylsilyl)furan (1a) with acetaldehyde gave $\text{diastereomerically pure}$ (3S^*, 1′R^*)-4,5-dihydro-3-(1′hydroxyethyl)-3-(trimethylsilyl)-2(3$\text{H}$)furanone (2a), which afforded selectively either (Z)- or (E)-α-ethylidene-γ-butyrolactone (3a) under proper conditions. Facile isomerization of 2a into $\text{diastereomerically pure}$ (3S^*, 1′R^*)-4,5-dihydro-3-&{1′-(trimethylsiloxy)ethyl}-2(3$\text{H}$)furanone (4) suggests an intriguing stereochemical outcome from 2a to (E)-3a via an enolate of 4.     

Chemoenzymatic synthesis of enantiopure geminally dimethylated cyclopropane-based C2- and pseudo-C2-symmetric diamines

Enantiopure (−)-(1S,3S)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxamide 2 and (+)-(1R,3R)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylic acid 3 were easily obtained from a multigram scale biotransformation of racemic amide or nitrile in the presence of Rhodococcus erythropolis AJ270 whole cell catalyst under very mild conditions. Coupled with efficient and convenient chemical manipulations, comprising mainly of the Curtius rearrangement, oxidation, and reduction reactions, chiral C₂-symmetric (1S,2S)-3,3-dimethylcyclopropane-1,2-diamine 6 and ((1R,3R)-3-(aminomethyl)-2,2-dimethylcyclopropyl)methanamine 8 and pseudo-C₂-symmetric (1S,3S)-3-(aminomethyl)-2,2-dimethylcyclopropanamine 11 were prepared. These were also transformed into the corresponding chiral salen derivatives 12, 13, and 14, respectively, in almost quantitative yields.     

Preparation and Crystal Structures of 4-(4′-Pyridylthio)-1-methylpyridinium Salts: Assembly of a Donor-Acceptor-Type Molecule Containing a Sulfide Bridge

A series of ionic 4-(4′-pyridylthio)-1-methylpyridinium salts with different counteranions (1, I⁻; 2, BF⁻₄; 3, PF⁻₆; and 4, OTf⁻, where OTf=trifluoromethanesulfonate) have been prepared. Structural analysis reveals that the cation exhibits a variety of stacking structures dependent on the anion. Compound 1 crystallizes in space group P2_1/n (#14), with a=10.764(3) Å, b=9.601(5) Å, c=13.105(3) Å, β=108.35(2), V=1285.4(8) ų, and Z=4. In this compound, each cation moiety is stacked in a helical arrangement along the c-axis. Compound 2, which is isomorphous to 1, has space group P2_1/n (#14), with a=11.647(2) Å, b=9.203(3) Å, c=13.232(2) Å, β=108.42(2), V=1345.6(5) ų, and Z=4. Compound 3 crystallizes in space group P2_1/n (#14), with a=8.06(1) Å, b=17.43(1) Å, c=10.30(1) Å, β=103.0(1), V=1410(3) ų, and Z=4. In this salt, the cation molecules assume a head-to-tail stacking arrangement, forming a polar pseudo 1-D chain. Compound 4 crystallizes in space group Pb? (#2), with a=7.585(4) Å, b=15.443(7) Å, c=6.775(4) Å, α=99.33(4), β=108.35(2)^o, γ=98.37(4), V=756.6(7) ų, and Z=2. The structure of 4 consists of a columnar stacking of pyridine moieties, with the cation moieties surrounded by the counteranions. Calculations show that the 4-(4′-pyridylthio)-1-methylpyridinium cation may be a good building block for second harmonic generation (SHG) materials, even though salts 1-4 crystallized in centrosymmetric structures and were SHG inactive.     

Synthesis of the dibenzo[f,h]phthalazine and dibenzo[f,h]cinnoline skeleton via a ‘Suzuki-Pd-catalyzed intramolecular arylation’ and a ‘Suzuki-Pschorr’ approach

Palladium-catalyzed intramolecular arylation of 2-benzyl-5-(2-bromophenyl)-4-phenylpyridazin-3(2H)-one yielded hitherto unknown 2-benzyldibenzo[f,h]phthalazin-1(2H)-one. The synthesis of this new tetracyclic pyridazinone from 2-benzyl-5-(2-aminophenyl)-4-phenylpyridazin-3(2H)-one via a Pschorr type reaction was also investigated. Similarly, the construction of 2-methyldibenzo[f,h]cinnolin-3(2H)-one from 2-methyl-5-(2-bromophenyl)-6-phenylpyridazin-3(2H)-one and 2-methyl-5-(2-aminophenyl)-6-phenylpyridazin-3(2H)-one is also reported. Removal of the N-benzyl protective group of 2-benzyl-dibenzo[f,h]phthalazin-1(2H)-one with AlCl₃ yielded unsubstituted dibenzo[f,h]phthalazin-1(2H)-one.     

Structural, spectral and thermal studies of substituted N-(2-pyridyl)-N′-phenylthioureas

N-2-(3-picolyl)-N′-phenylthiourea, 3PicTuPh, monoclinic, P2₁/n, a=7.617(2) b=7.197(5), c=22.889(5) Å, β=94.63(4)°, V=1250.7(1) Å³ and Z=4; N-2-(4-picolyl)-N′-phenylthiourea, 4PicTuPh, triclinic, P-1, a=7.3960(5), b=7.9660(12), c=21.600(3) Å, α=86.401(4), β=84.899(8), γ=77.769(8)°, V=1237.5(3) Å³ and Z=4; N-2-(5-picolyl)-N′-phenylthiourea, 5PicTuPh, monoclinic, P2₁/c, a=14.201(1), b=4.905(3), c=17.689(3) Å, β=91.38(1)°, V=1231.8(7) Å³ and Z=4; N-2-(6-picolyl)-N′-phenylthiourea, 6PicTuPh, monoclinic, C2/c2, a=14.713(1), b=9.367(1), c=18.227(1) Å, β=92.88(1)°, V=2515.5(1) Å³ and Z=8 and N-2-(4,6-lutidyl)-N′-phenylthiourea, 4,6LutTuPh, monoclinic, C2/c, a=11.107(2), b=11.793(2), c=20.084(4) Å, β=96.10(3)°, V=2616(1) Å³ and Z=8. Intramolecular hydrogen bonding between N′H and the pyridyl nitrogen and intermolecular hydrogen bonding involving the thione sulfur are affected by substitution of the pyridine ring, as is the planarity of the molecule. ¹H NMR studies in CDCl₃ show the NH′ hydrogen resonance considerably downfield from other resonances in the spectrum for each thiourea.     

Synthesis and crystal structures of novel glycoluril carboxylic acids conglomerates

The two novel conglomerates were obtained by crystallization of racemic (2'S,3aS,6aR)/(2'R,3aR,6aS) (glycoluril-1-yl)-3-methylbutanoic acid and (2'R,3aR,6aR)/(2'S,3aS,6aS) (4,6-dimethylglycoluril-1-yl)pentanoic acid synthesized by highly diastereoselective condensation of 4,5-dihydroxy- imidazolidin-2-ones with racemic ureido acids. The differences in the molecular geometry of synthesized racemates were studied by X-ray diffraction that showed them to crystallize as conglomerates in non-centrosymmetric space groups Pna2₁ and P2₁2₁2₁, respectively     

Crystal structures of bis(AZIDO)bis(2-morpholin-4-ylethylamino)copper(II) and bis{2,4-dibromo-6-[(2-morpholin-4-ylethylimino)methyl] phenolato}copper(II)

Two new copper(II) complexes [Cu(MEA)₂(N₃)₂] (1) and [Cu(BMP)₂] (2), where MEA and BMP are 2-morpholin-4-ylethylamine and 2,4-dibromo-6-[(2-morpholin-4-ylethylimino)methyl]phenolate respectively, are prepared and characterized using elemental analysis, FT-IR spectroscopy, and X-ray single crystal diffraction. The crystal of 1 belongs to the triclinic system, space group P-1, with a = 6.661(2) Å, b = 8.440(3) Å, c = 8.913(3) Å, α = 102.032(3)°, β = 107.899(2)°, γ = 98.242(3)°, V = 454.6(3) ų, Z = 1, D _c = 1.490 g/cm³, R ₁ = 0.0226, and wR ₂ = 0.0564. The crystal of 2 belongs to the monoclinic system, space group P2₁/c, with α = 7.0707(7) Å, b = 15.438(1) Å, c = 14.227(1) Å, β = 96.659(2)°, V = 1542.5(3) ų, Z = 2, D _c = 1.821 g/cm³, R ₁ = 0.0437, and wR ₂ = 0.1041. In each complex, the Cu atom is in a square planar coordination. The molecules of 1 are linked through intermolecular N-H...N and N-H...O hydrogen bonds to form layers parallel to the ab plane. The molecules of 2 are linked through intermolecular C-H...Br hydrogen bonds to form a 3D network.     

Synthesis of new aminocyclitols by selective epoxidation of N-benzyl-N-methyl-2-cyclohepten-1-amine and tert-butyl 4-[benzyl(methyl)amino]-2,3,4,7-tetrahydro-1H-azepine-1-carboxylate

Synthesis of N-benzyl-N-methyl-2-cyclohepten-1-amine and tert-butyl 4-[benzyl(methyl)amino]-2,3,4,7-tetrahydro-1H-azepine-1-carboxylate from cyclic allyl acetates was performed. The features of stereoselective epoxidation of these substrates were investigated. The subsequent epoxide opening with water led to the formation of new pseudosaccharides, (1RS,2RS,3RS)-3-[benzyl(methyl)amino]-1,2-cycloheptanediol, (1RS,2RS,3SR)-3-[benzyl(methyl)amino]-1,2-cycloheptanediol, and (3RS,4RS,5RS)-3-[benzyl(methyl)amino]-4,5-azepanediol.     

Studies of the oxovanadium-organophosphonate system: Hydrothermal synthesis and crystal structure of the mixed valence cluster [V5O9(PhPO3)3(PhPO3H)2]2− and a comparison to the structure of the fully oxidized parent cluster [V5O7(OCH3)2(PhPO3)5]1−

The room temperature reaction of (Bu₄N)₃V₅O₁₄ with PhPO₃H₂ in methanol yields the pentanuclear V(V) cluster (Bu₄N)[V₅O₇(OCH₃)₂(PhPO₃)₅]·CH₃OH (1·CH₃OH). In contrast, the hydrothermal reaction of (Ph₄P) [VO₂Cl₂], PhPO₃H₂ and (NH₄)H₂PO₄ at 125°C for 96 hr yields the mixed valence V(IV)/V(V) species (Ph₄P)₂[V₅O₉(PhPO₃)₃(PhPO₃H)₂] (3). While the anions of both 1 and 3 exhibit a pentanuclear core, the structural consequences of 1-electron reduction of the fully oxidized cluster of 1 to produce 3 are quite dramatic, including reduction in coordination numbers at two vanadium sites and protonation of two phosphonate oxygen sites with concomitant structural reorganization. Crystal data: 1, monoclinic P2₁/n,a=12.167(2) Å,b=23.348(5) Å,c=22.508(5) Å,β=98.49(2)°,V=6323.9(19) ų,Z=4,D _calc=1.558 g cm^?3; 3, triclinic, $P\bar 1$ ,a=13.478(3) Å,b=14.399(3) Å,c=23.638(5) Å,α=72.53(2)°,β=85.58(2)°,γ=69.88(4)°,V=4107.0(16) ų,Z=2, D_calc=1.479 g cm^?3.     

Preliminary studies on a novel synthesis of β-amino acids: stereocontrolled transformation of d- and l-glyceraldehyde into 3-amino-2-(2′,2′-dimethyl-1′,3′-dioxolan-4′-yl)propanoic acids

A stereocontrolled synthesis of the methyl ester of (2S)-3-amino-2-((4′S)-2′,2′-dimethyl-1′,3′-dioxolan-4′-yl)propanoic acid from d-glyceraldehyde is described for the first time. This method involves the stereoselective Michael addition of the lithium salt of tris(phenylthio)methane to (S)-2,2-dimethyl-4-((E)-2-nitrovinyl)-1,3-dioxolane followed by hydrolysis of the resulting (4S)-2,2-dimethyl-4-((2′S)-3′-nitro-1′,1′,1′-tris(phenylthio)propan-2′-yl)-1,3-dioxolane to (2S)-methyl 2-((4′S)-2′,2′-dimethyl-1′,3′-dioxolan-4′-yl)-3-nitropropanoate, which was finally reduced to the target compound. A similarly stereocontrolled transformation of l-glyceraldehyde into (2R)-methyl 3-amino-2-((4′R)-2′,2′-dimethyl-1′,3′-dioxolan-4′-yl)propanoate is also described.